Companies: 10,762     total market cap: NZ$231.238 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1568
Rank
NZ$22.99 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$229.14
Share price
2.35%
Change (1 day)
18.38%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): NZ$1.08 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are NZ$2.86 Billion. , an increase over its 2024 earnings that were of NZ$1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 NZ$1.10 B3.9%
2024 NZ$1.06 B96.41%
2023 NZ$0.54 B41.13%
2022 NZ$0.38 B73.74%
2021 NZ$0.22 B-8.82%
2020 NZ$0.24 B77.78%
2019 NZ$0.13 B49.83%
2018 NZ$91.08 M-142.57%
2017 -NZ$0.22 Billion-14.73%
2016 -NZ$0.26 Billion53.15%
2015 -NZ$0.17 Billion46.25%
2014 -NZ$0.12 Billion29.66%
2013 -NZ$86.41 Million-3530.8%
2012 NZ$2.51 M-95.73%
2011 NZ$59 M
2009 -NZ$82.95 Million-45.38%
2008 -NZ$0.16 Billion-58.87%
2007 -NZ$0.37 Billion87.3%
2006 -NZ$0.2 Billion351.97%
2005 -NZ$43.61 Million-52.09%
2004 -NZ$91.03 Million-10.98%
2003 -NZ$0.11 Billion
2001 -NZ$76.33 Million
1999 -NZ$34.43 Million108.32%
1998 -NZ$16.53 Million
1996 NZ$5.04 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.72 B 1,501.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.47 B 936.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$44.75 B 3,942.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.14 B-86.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72.64 Million-106.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$87.92 M-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.35 Million-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$2.83 B 156.38%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com